Sarepta Therapeutics, Inc.
—- Market cap
- —
- Debt
- +$828.97M
- Cash
- −$939.65M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $14.01B · View financials
Decision snapshot: SRPT stock price vs MKC: inconclusive — current versus $42.64 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MKC's multiple
Implied fair value · at SRPT's multiple
Needs SRPT P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SRPT FY 2025 (ended Dec 31, 2025) · MKC FY 2025 (ended Nov 30, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 77% equity / 23% debt · EV / Revenue 2.64x · EV / EBITDA 11.30x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAREPTA THERAPEUTICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
McCORMICK & COMPANY, INCORPORATED · implied price per share
Bear
$19.17
Base
$25.77
Bull
$34.68
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.73x
0.72x
Net debt / EBITDA
Leverage against operating earnings
0.17x
2.52x
Cash and equivalents
Liquid reserves on the balance sheet
$939.65M
$95.90M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
SRPT vs AMGN
BIOMARIN PHARMACEUTICAL INC
SRPT vs BMRN
Replimune Group, Inc.
SRPT vs REPL
PTC THERAPEUTICS, INC.
SRPT vs PTCT
GENERAL MILLS INC
SRPT vs GIS
HORMEL FOODS CORP /DE/
SRPT vs HRL
CONAGRA BRANDS INC.
SRPT vs CAG
Kraft Heinz Co
SRPT vs KHC
CAMPBELL'S Co
SRPT vs CPB
J M SMUCKER Co
SRPT vs SJM
Mondelez International, Inc.
SRPT vs MDLZ
$828.97M
$4.12B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.